Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2002American Journal of Hematology

High‐titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors

View Full Paper
Ask AI
Bookmark
Share

Authors

NBN. BayaniMRMichel RuginaHôpital Intercommunal de CréteilLHLaurence Haddad‐Vergnes

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bayani et al. (2002) studied this question.

synapsesocial.com/papers/6a21cf58cfdd5cd1d31597bahttps://doi.org/10.1002/ajh.10172
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Autoimmunity Resulting From Cytokine Treatment Predicts Long-Term Survival in Patients With Metastatic Renal Cell Cancer1999 · 88 citations
  2. 2Factor V anticoagulants: clinical, biochemical, and immunological observations1970 · 59 citations
  3. 3A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIII1981 · 787 citations
  4. 4Distinguishing Plasma Lupus Anticoagulants from Anti-Factor Antibodies Using Hexagonal (II) Phase Phospholipids1989 · 110 citations